Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.43%
Stock 64.97%
Bond 34.36%
Convertible 0.00%
Preferred 0.00%
Other 0.24%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.20%    % Emerging Markets: 0.82%    % Unidentified Markets: -0.02%

Americas 90.97%
90.61%
Canada 62.98%
United States 27.63%
0.36%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 8.17%
United Kingdom 1.71%
6.46%
Denmark 0.62%
France 3.06%
Germany 0.62%
Ireland 0.32%
Italy 0.05%
Netherlands 1.35%
Spain 0.13%
Sweden 0.10%
Switzerland 0.20%
0.00%
0.00%
Greater Asia 0.88%
Japan 0.18%
0.00%
0.00%
0.70%
China 0.40%
India 0.30%
Unidentified Region -0.02%

Bond Credit Quality Exposure

AAA 17.72%
AA 20.33%
A 21.82%
BBB 27.39%
BB 1.06%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.42%
Not Available 11.27%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.26%
Materials
4.94%
Consumer Discretionary
5.08%
Financials
14.12%
Real Estate
1.13%
Sensitive
29.41%
Communication Services
2.81%
Energy
4.83%
Industrials
8.84%
Information Technology
12.93%
Defensive
11.29%
Consumer Staples
4.95%
Health Care
4.05%
Utilities
2.29%
Not Classified
34.04%
Non Classified Equity
0.11%
Not Classified - Non Equity
33.93%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 13.62%
Corporate 51.66%
Securitized 0.00%
Municipal 22.56%
Other 12.17%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.21%
Less than 1 Year
2.21%
Intermediate
85.98%
1 to 3 Years
3.72%
3 to 5 Years
5.47%
5 to 10 Years
76.79%
Long Term
11.81%
10 to 20 Years
2.21%
20 to 30 Years
8.17%
Over 30 Years
1.44%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial